Zuanic & Associates

The introduction of recreational cannabis sales has brought about significant shifts in the medical marijuana (MMJ) landscape across several states, impacting sales and patient counts. In many states, MMJ sales have experienced double-digit declines following the onset of recreational sales....

Maryland's recreational cannabis sales, which began in July 2023, surged impressively in just the first month, reaching $87.3 million. According to analysis firm, Zuanic & Associates, this significant growth, although promising, falls slightly short of expectations given the state's...

The Canadian cannabis market is abuzz with competition. The latest data from Hifyre, as analyzed by Zuanic & Associates, highlights a heated race in the pre-roll segment. In the second quarter of 2023, a staggering 1,475 pre-roll SKUs were registered, originating from a diverse pool of 148...

Cannabis pre-rolls are emerging as a key driver of the growth of Canada’s recreational cannabis market. Which other cannabis products have seen significant growth in the second quarter of 2023? And, how do these trends provide valuable insights for industry players in Canada's...

The potential of rescheduling and removing Tax Rule 280E could boost profits for U.S. businesses. However, Zuanic and Associates' latest report reveals complexities and overlooked consequences. What is the best option for unlocking the cannabis industry's potential: exploring...

How are major players in the cannabis sector handling their tax obligations, and what does it reveal about their financial strategies? A recent equity report by Zuanic & Associates sheds light on the tax payments and liabilities of 16 Multi-State Operators (MSOs) in the industry during CY22....

Will the rescheduling of cannabis fuel a boom in cannabis stocks? Analysts from Z&A delve into the pros and cons of MSOs and cannabis rescheduling in their latest equity research report. Re-scheduling Vs. De-scheduling: What Is The Difference? Re-scheduling cannabis refers to the process of...

Benzinga recently reviewed the balance sheet and cash flow trends of Canadian LPs (licensed producers). Zuanic & Associates presents crucial factual key findings: StatCan (official government source) reported May cannabis retail sales (rec) of $415.6Mn, up 1.2% MoM, and -2.1% in day-adjusted...

In an exclusive preview from Zuanic & Associates' recent cannabis equity research report, Benzinga reveals four key predictions for the next 18 months. The SAFE Banking bill is expected to pass in the fall of 2024. Key Senate players will aim for a "midpoint" compromise on add-...

Within the East Coast Cannabis Market, Maryland has emerged as a pivotal player and captivated the attention of experts at equity research firm Zuanic & Associates (Z&A). Unlike its neighboring states, which are grappling with illicit markets and slow rollouts, Maryland made a decisive move...

Zuanic & Associates' latest Key States equity report takes us "in the weeds" with state-level data, revealing crucial insights and trends that may impact the industry in the year ahead. Key Trends: State-Level Data Despite fundamentals taking a backseat to federal reform news flow...

Zuanic & Associates (Z&A), has launched its research service with thematic and macro reports, followed by selective equity stock coverage. Its expert evaluation framework guides you in making informed choices for cannabis stock investments. Highlights Of Zuanic & Associates'...